Relative Bioavailability of Phase II and Phase III Formulations of AZD0530

of both the Phase II and Phase III AZD0530 125mg tablet variants (A and B) in a random order.

Part II: Single doses of AZD0530 125mg oral solution and 2 out of 4 125mg tablet variants (C, D, E and F) in a random order.